PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.44 - 1.45
1.18 - 2.36
61.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
100.00%
Revenue growth of 100.00% while 1475.HK is flat. Bruce Berkowitz would check if a small edge can widen further.
-100.00%
Negative gross profit growth while 1475.HK is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative operating income growth while 1475.HK is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
-100.00%
Negative net income growth while 1475.HK stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-101.92%
Negative EPS growth while 1475.HK is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-101.92%
Negative diluted EPS growth while 1475.HK is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-89.25%
Dividend reduction while 1475.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-309.88%
Negative OCF growth while 1475.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-54.96%
Negative FCF growth while 1475.HK is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-99.58%
Negative 10Y revenue/share CAGR while 1475.HK stands at 55.81%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-99.16%
Negative 5Y CAGR while 1475.HK stands at 38.71%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-99.62%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-173.07%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-178.15%
Negative 5Y OCF/share CAGR while 1475.HK is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-168.71%
Negative 3Y OCF/share CAGR while 1475.HK stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-105.22%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-127.49%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-106.83%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
536.80%
Dividend/share CAGR of 536.80% while 1475.HK is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
988.65%
Dividend/share CAGR of 988.65% while 1475.HK is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
33.80%
3Y dividend/share CAGR of 33.80% while 1475.HK is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-56.95%
We have a declining book value while 1475.HK shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.